Table 3.
Association between clinicopathologic stage and gene expression profiles (from logistic regression analysis). Data are listed in ascending odds ratio (OR) values for each clinicopathologic stage. Only associations with confidence intervals (CI) not overlapping with 1 and P <0.05 are shown.
Tumour stage | Genomic variable | OR | 95% CI | P |
---|---|---|---|---|
AJCC | Minguez_Vascular invasion [9] | 4.50 | 1.05-19.22 | 0.042 |
Villanueva_KRT19 [6] | 4.80 | 1.13-20.46 | 0.034 | |
Novak_Met [50] | 6.00 | 1.18-30.58 | 0.031 | |
Andersen_KRT19 [27] | 6.75 | 1.51-30.16 | 0.012 | |
Coulouarn_TGF-beta [28] | 6.75 | 1.51-30.16 | 0.012 | |
Boyault_G3 [25] | 13.36 | 2.33-76.48 | 0.004 | |
BCLC | Villanueva_KRT19 [6] | 5.07 | 1.19-21.51 | 0.028 |
Novak_Met [50] | 6.29 | 1.24-31.96 | 0.027 | |
Boyault_G3 [25] | 7.08 | 1.52-33.03 | 0.013 |
AJCC: American joint committee on cancer
BCLC: Barcelona Clinic Liver Cancer
AJCC: T1/T2 vs. T3/T4
BCLC: A vs. B/C